Crossmark

A case of frequent hypoglycemic attacks successfully controlled with capecitabine plus temozolomide and 177Lu-DOTATATE peptide receptor radionuclide therapy in a patient with recurrent pancreatic insulinoma

Crossref DOI link: https://doi.org/10.1007/s12328-023-01824-8

Published Online: 2023-07-05

Published Print: 2023-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Terashima, Takeshi

Yamashita, Tatsuya https://orcid.org/0000-0002-3602-8086
Takemura, Naoki

Inaki, Anri

Shimizu, Akinori

Harada, Kenichi

Yamashita, Taro

Kinuya, Seigo

Hanada, Keiji
License Information

Text and Data Mining valid from 2023-07-05

Version of Record valid from 2023-07-05
More Information

Article History

Received: 3 March 2023

Accepted: 18 June 2023

First Online: 5 July 2023

Declarations

:

: The authors declare no potential conflicts of interest associated with this manuscript.

: We obtained the patient’s consent for publication of clinical, therapeutic and demographic data.

Document is current

Any future updates will be listed below